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Background: Myocardial T1 relaxation times have been reported to be markedly abnormal in diverse myocardial
pathologies, ascribed to interstitial changes, evaluated by T1 mapping and calculation of extracellular volume (ECV).
T1 mapping is sensitive to myocardial water content of both intra- and extracellular in origin, but the effect of
intravascular compartment changes on T1 has been largely neglected. We aimed to assess the role of intravascular
compartment on native (pre-contrast) T1 values by studying the effect of adenosine-induced vasodilatation in patients
with severe aortic stenosis (AS) before and after aortic valve replacement (AVR).
Methods: 42 subjects (26 patients with severe AS without obstructive coronary artery disease and 16 controls)
underwent cardiovascular magnetic resonance at 3 T for native T1-mapping (ShMOLLI), first-pass perfusion
(myocardial perfusion reserve index-MPRI) at rest and during adenosine stress, and late gadolinium enhancement (LGE).
Results: AS patients had increased resting myocardial T1 (1196 ± 47 ms vs. 1168 ± 27 ms, p = 0.037), reduced MPRI
(0.92 ± 0.31 vs. 1.74 ± 0.32, p < 0.001), and increased left ventricular mass index (LVMI) and LGE volume compared to
controls. During adenosine stress, T1 in AS was similar to controls (1240 ± 51 ms vs. 1238 ± 54 ms, p = 0.88), possibly
reflecting a similar level of maximal coronary vasodilatation in both groups. Conversely, the T1 response to stress was
blunted in AS (ΔT1 3.7 ± 2.7% vs. 6.0 ± 4.2% in controls, p = 0.013). Seven months after AVR (n = 16) myocardial T1 and
response to adenosine stress recovered towards normal. Native T1 values correlated with reduced MPRI, aortic valve
area, and increased LVMI.
Conclusions: Our study suggests that native myocardial T1 values are not only influenced by interstitial and intracellular
water changes, but also by changes in the intravascular compartment. Performing T1 mapping during or soon after
vasodilator stress may affect ECV measurements given that hyperemia alone appears to substantially alter T1 values.
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Myocardial T1 determination using cardiovascular mag-
netic resonance (CMR) is a technique that can be used to
provide a quantitative measure of myocardial water, with-
out the need for exogenous contrast agents [1]. Native
(pre-contrast) T1 values are elevated in conditions asso-
ciated with increased myocardial water content such as
acute myocardial infarction [2,3], oedema [4], acute myo-
carditis [5] and Takotsubo cardiomyopathy [6]. T1 values
have also been shown to be elevated in conditions associ-
ated with myocardial fibrosis and expanded interstitial
space such as dilated cardiomyopathy, hypertrophic car-
diomyopathy [7] and aortic stenosis [8]. Other conditions
associated with T1 changes are protein deposition in
amyloid (increased T1 values) [9], and lipid deposition in
Anderson-Fabry disease [10] and iron deposition due to
hemorrhage (low T1 values) [11].
Despite the rapidly growing applications, the T1 sensi-
tivity to detect disease is not fully understood and the
measurements depend somewhat on the particular choice
of methods [12-14]. In particular, the documented native
T1 elevation in diffuse fibrosis cannot originate directly
from collagen itself, which in large enough concentrations
would tend to reduce T1 similarly to other proteins [15].
Thus, the observed increase in native T1 values may be
due to increase in tissue water content independently of
its extra/intracellular or intra/extravascular origin. How-
ever, the influence of intravascular water volume to the T1
values has never been investigated before, either in normal
or pathological conditions.
In this work, we aimed to examine the impact of in-
duced vasodilatation on the native T1 values following ad-
enosine stress perfusion. This allowed assessment of the
potentially reduced vascular reactivity in AS due to coron-
ary microvascular dysfunction [16]. We also investigated if
these changes were reversible after aortic valve replace-
ment (AVR). We hypothesized that T1 values depend on
the degree of coronary vascular recruitment and would
increase under adenosine stress perfusion, and that the




We prospectively recruited 26 patients with severe AS
without obstructive coronary artery disease (CAD) on
invasive coronary angiography scheduled prior to AVR.
Severe AS was diagnosed based on the previously estab-
lished criteria [17]. Briefly patients were included if the
aortic valve area (AVA) was ≤1.0 cm2, peak aortic valve gra-
dient was 64 mmHg and there was no other significant
valvular pathology on echocardiogram. Patients were ex-
cluded if they had systolic blood pressure (BP) >160 mmHg
and diastolic BP >90 mmHg, LVEF <50%, contraindicationsto CMR, glomerular filtration rate <60 ml/min, underlying
cardiomyopathy or known history of CAD. Of these pa-
tients, 16 had a repeat CMR scan 7 months after AVR. Ten
patients did not have a follow-up scan due to reasons such
as death (2 patients), pacemaker implantation (1 patient),
hospital admission due to unrelated to cardiac causes (1 pa-
tient), lost to follow-up (3 patients) and declined a repeat
scan (3 patients). In addition, healthy volunteers with no
prior cardiac history or known cardiac risk factors, not on
any cardiovascular medications and with a normal ECG
served as controls. All subjects gave written informed con-
sent to participate in the study and ethical approval from
the National Research Ethics Service committee South
Central – Berkshire was granted for all study procedures.
Cardiovascular magnetic resonance
CMR was performed in a 3 Tesla MR system (TIM Trio;
Siemens Healthcare, Erlangen, Germany). Study partici-
pants were instructed to avoid caffeine-containing food
and drinks for at least 24 hours prior to CMR scan. Cine
imaging was performed using standard methods [18]. At
rest, 3 short-axis images of T1 maps were acquired using
the shortened modified look-locker inversion recovery
(ShMOLLI) sequence as previously described [19]. Adeno-
sine stress perfusion imaging was performed as previously
described [20,21]. Briefly, adenosine (140 μg/kg/min) was
infused intravenously for at least 3 minutes, followed by ac-
quisition of a single mid-ventricular slice (identical to the
one acquired at rest) of T1 map. Then stress perfusion im-
aging was performed immediately after stress T1 imaging,
using a bolus a gadolinium-based contrast (Gadodiamide,
Omniscan; GEHealthcare) at a dose of 0.03 mmol/kg
followed by a saline flush. After discontinuing adenosine,
rest perfusion images were acquired 20 minutes after the
stress study to allow sufficient time for contrast washout.
For late gadolinium enhancement (LGE), an additional
bolus of 0.1 mmol/kg gadodiamide was administered (total
dose: 0.16 mmol/kg) immediately after rest perfusion. The
LGE images were acquired as previously described [22].
Cardiac magnetic resonance image analysis
Analysis of cardiac volumes, function and mass was per-
formed according to the standard methods [18]. AVA was
measured from direct planimetry in cine imaging. Infor-
mation on the peak aortic valve gradient was obtained
from the clinical echocardiogram performed as part of
routine clinical care. For the analysis of ShMOLLI T1-
maps, the LV myocardium of the mid-axial slice acquired
at baseline was contoured by a blinded observer (EL)
using dedicated software, as previously described [6] pro-
viding a single average myocardial T1 value per each indi-
vidual. The average values were also calculated after
manually excluding areas with focal LGE. The myocardial
T1 value from the stress mid-ventricular ShMOLLI T1
Table 1 Baseline clinical characteristics of severe AS








Age (years) 67.8 ± 9 63.3 ± 3.4 0.06
Male, n (%) 19 (73) 8 (53) 0.16
Past medical history, n (%)
Hypertension 10 (38) −
Diabetes 4 (15) −
Medications, n (%)
Metformin 4 (15) −
ACE-I/ARB-II 7 (27) −
Beta-blockers 5 (19) −
Body mass index (kg/m2) 27.8 ± 4.5 27.0 ± 3.8 0.38
Systolic blood pressure
(mmHg)
134.4 ± 18.1 131.0 ± 11.0 0.51
Diastolic blood pressure
(mmHg)
74.4 ± 9.4 76.5 ± 10.2 0.51
Heart rate (bpm) 66.1 ± 9.4 64.3 ± 10.5 0.58
Peak AV gradient (mmHg)* 83.1 ± 14.6 −
CMR findings
Aortic valve area (cm2) 0.82 ± 0.02 4.04 ± 0.75 <0.001
LV end-diastolic volume (ml) 143.2 ± 44.4 133.7 ± 33.1 0.47
LV ejection fraction (%) 74.5 ± 5.8 68.8 ± 6.4 0.005
LV mass index (g/m2) 96.0 ± 31.2 55.8 ± 13.9 <0.001
Presence of LGE, n (%) 21 (81) 0 <0.001
Myocardial T1 (ms) 1196 ± 47 1168 ± 27 0.037
Values are mean ± SD or percentages. ACE indicates angiotensin-converting
enzyme-inhibitors; ARB, angiotensin-receptor antagonist-II; LGE, CMR,
cardiovascular magnetic resonance; late gadolinium enhancement; LV,
left ventricular.
*Based on echocardiogram.
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For perfusion analysis, briefly, 3 contours (epicardial, endo-
cardial and LV blood pool) were drawn on a single image
and propagated throughout the perfusion series. The myo-
cardium was divided into segments based on the American
Heart Association (AHA) segmentation model. Signal
intensity (SI) versus time curves were generated and
normalized to the left ventricular (LV) blood pool up-
slope. Myocardial perfusion reserve index (MPRI) was
defined as the ratio of stress to rest relative upslope, as
previously described [23]. LGE quantification was per-
formed using cmr42 software (version 4.0, Circle Car-
diovascular Imaging) by a blinded observer (AL). The
full-width-half-maximum (FWHM) technique was used
to quantify fibrosis as previously described [24]. The
volume of focal fibrosis was expressed as the LGE mass
(g) and also as a percentage of total myocardial mass.
Statistical analysis
All data are expressed as mean ± standard deviation or
median (interquartile range), and checked for normality
using Kolmogorov–Smirnov test. Categorical data are
presented as numbers and percentages. Comparisons be-
tween the 2 groups were performed using Student t-test,
the chi-square test, or Fisher’s exact test as appropriate.
Bivariate correlations were performed using Pearson’s or
Spearman’s method as appropriate. Comparisons between
pre- and post-AVR measurements in AS patients and rest
and stress T1 values were performed using 2-tailed paired
t-test. Comparisons between AS patients and controls
at baseline and post-AVR were performed using Stu-
dent t-test or Mann–Whitney U test as appropriate. A
P-value <0.05 was considered significant. All statistical




Patient characteristics during the baseline examination
are summarized in Table 1. There were no significant
differences in age, sex, body mass index, BP and pulse
rate from controls. In the AS group 38% were hyperten-
sive but their BP were well controlled. There were a
small number of diabetics (15%) in the AS patient group,
but their blood glucose and lipid levels were similar to
the controls (results not shown).
Assessment of left ventricular mass, function, focal
fibrosis and myocardial T1
CMR results are also summarized in Table 1. AS pa-
tients had significantly higher LVMI and LV ejection
fraction when compared to controls. There was high
burden of myocardial fibrosis in AS patients (absolute
volume of focal fibrosis 29.3 g, IQR 16.8-58.8 g; % LVmass 18.3 ± 9.4%). None of the controls had LGE. As
previously reported [8], native myocardial T1 was signifi-
cantly higher in AS patients when compared to normal
controls and remained elevated after excluding the areas
with focal LGE (1199 ± 46 ms, p = 0.025 vs. normal
controls).
Myocardial T1 and perfusion reserve under adenosine
vasodilator stress
Both AS patients and controls had equivalent rises in
rate pressure product (RPP) during adenosine stress
(baseline 8800 ± 1600 mmHg · beats/min in AS vs. 8100 ±
1500 mmHg · beats/min in controls, p = 0.19) and (stress
11,400 ± 2500 mmHg · beats/min in AS vs. 11800 ±
2800 mmHg · beats/min in controls, p = 0.69).
Importantly we now report that T1 values were signifi-
cantly increased during adenosine stress in both AS pa-
tients (from 1196 ± 47 ms to 1240 ± 51 ms, p < 0.001)
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54 ms, p < 0.001). Interestingly, both groups exhibited simi-
lar maximal T1 values during adenosine stress (1240 ±
55 ms in AS vs. 1238 ± 54 ms in normal controls, p = 0.90).
Given the T1 increase at rest, the stress response was
blunted in AS patients, as expressed by significantly
smaller absolute ΔT1 (44 ± 33 ms in AS vs. 70 ± 49 ms in
normal controls, p = 0.013) and percentage of ΔT1 (3.7 ±
2.7% in AS vs. 6.0 ± 4.2% in normal controls, p = 0.013). As
expected, myocardial perfusion reserve was significantly re-
duced in AS patients when compared to normal controls
(MPRI 0.92 ± 0.31 vs. 1.74 ± 0.32, p < 0.001).
Relationship amongst T1 values, perfusion and focal
fibrosis (LGE)
Resting T1
Resting T1 values increased with increasing LVMI (r = 0.59,
p < 0.001) and absolute LGE volume (r= 0.46, p = 0.03) but
not LGE volume as % of LV mass (r = 0.41, p = 0.066). Fur-
thermore, T1 values had an inverse correlation with MPRI
(r= −0.51, p = 0.001) and AVA (−0.35, p = 0.026). These re-
lationships and their significance were preserved when the
correlation analysis was repeated excluding segments show-
ing focal LGE (results not shown).
Stress T1
Stress T1 values had no significant correlations with LVMI,
MPRI or LGE. The degree of stress T1 response (%ΔT1)
showed weak negative correlation with LVMI but no sig-
nificant correlation with MPRI or LGE.
Cardiac MRI post AVR (n = 16)
These results are summarized in Table 2. As expected,
there was substantial reduction of LVH and improvement
in perfusion reserve 7 months following AVR. There wasTable 2 CMR and before and after AVR (n = 16)
Pre AVR Post AVR Normal
Myocardial T1 (ms) 1197 ± 35 1167 ± 43* 1168 ± 27
Stress myocardial
T1 (ms)
1241 ± 44 1237 ± 53† 1238 ± 54
ΔT1 (%) 3.7 ± 2.9 6.0 ± 2.0* 6.0 ± 4.2
Myocardial perfusion
reserve index
0.97 ± 0.38 1.63 ± 0.56* 1.74 ± 0.32
Left ventricular mass
index (g/m2)
97.4 ± 29.0 68.8 ± 16.4‡ 55.8 ± 13.9
Absolute LGE
Mass (g)
25.0 (14.9-54.3) 17.3 (13.6-30.4)** -
LGE % of myocardium (%) 17.5 ± 10.6 16.4 ± 10.8*** -
Values are mean ± SD or median (interquartile range). LGE indicates late
gadolinium enhancement.
*p < 0.05 vs pre AVR and >0.05 vs normal; †p > 0.05 vs pre AVR and normal;
‡p < 0.05 vs pre AVR and normal; **p < 0.05 vs pre AVR; ***p > 0.05 vs pre AVR.
LGE data were based on n = 14 who had LGE + .significant reduction in resting T1 values post AVR with
no significant difference compared to controls. More im-
portantly, the diminished T1 response to adenosine stress
pre-AVR improved significantly to normal level post-AVR
(Figures 1 and 2), as shown by an increase in T1 reactivity
(absolute ΔT1 44 ± 34 ms pre-AVR to 70 ± 24 ms post-
AVR, p = 0.02 [paired t test for n = 16]; post-AVR ΔT1 vs.
controls, p = 0.57). Examples of CMR images of a patient
with severe AS pre and post AVR and a normal control
are shown in Figure 3. The absolute volume of focal fibro-
sis decreased post-AVR, but the percentage LV myocar-
dium that showed fibrosis was unchanged compared to
pre-AVR.
Discussion
Increased myocardial T1 values has previously been
linked to expansion of interstitial space owing to inter-
stitial fibrosis based on native T1 and ECV measure-
ments using post-contrast T1 techniques [25,26]. In this
study, we confirm that resting myocardial T1 values are
elevated in severe AS patients compared to normal con-
trols and correlate with markers of disease severity, such
as aortic valve area, LVH [8], and myocardial perfusion
reserve. We have shown for the first time that T1 values
in both AS patients and normal controls increase in re-
sponse to adenosine vasodilator stress. Interestingly, the
achieved level of maximal stress T1 was the same in AS
patients as in controls, with blunted stress T1 response
(reduced ΔT1) in AS owing to higher resting T1. Im-
portantly, the abnormal resting myocardial T1 and the re-
duced ΔT1 stress response normalized seven monthsFigure 1 Rest and adenosine stress T1 values. Changes in
myocardial T1 values (rest and stress) before and after aortic valve
replacement and normal controls. Error bars represent the 95%
confidence interval for the mean.
Figure 2 Myocardial T1 reactivity to adenosine stress pre and
post AVR. Error bars represent the 95% confidence interval for
the mean.
Figure 3 Examples of stress T1 imaging. Cardiovascular magnetic reson
(from top to bottom panels). From left to right, examples of AV cine, stress
imaging (with MPRI values). White arrows show circumferential perfusion d
AS = aortic stenosis; AVR = aortic valve replacement; AV = aortic valve; ΔT1 =
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fibrosis (based on LGE% of LV mass) post AVR, in line
with a previous study [27]. Furthermore, others showed
no significant diffuse fibrosis regression 6 months post
AVR measured by equilibrium contrast [28]. These find-
ings are hypothesis-generating, raising the possibility that,
in severe AS, increased resting myocardial T1 may have a
signal origin specifically in the intravascular compartment,
rather than be explained solely by diffuse myocardial fi-
brosis in the interstitial compartment which we did not
expect previously [7,8] and also as suggested by others
[8,26,28]. Increased resting coronary blood flow in severe
AS as adaptation for the increased demands of the hyper-
trophied myocardium has previously been demonstrated
[16,29-31], despite inadequate growth of vascular bed,
characteristic of pressure overload hypertrophy [32].Influence of intravascular myocardial blood volume on
myocardial T1 relaxation times
T1-mapping is typically known for edema imaging and
as a surrogate for diffuse myocardial fibrosis in the ab-
sence of other causes of interstitial expansion (such as
edema and amyloidosis) [1], but in principle it measures
global water content in tissue, whether intra-cellular,ance images show examples of AS pre and post AVR, and normal
T1 (with ΔT1 values between rest and stress), and stress perfusion
efect in AS pre AVR which is not seen in post AVR or normal.
change in T1; MPRI = myocardial perfusion reserve index.
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fluence of intravascular myocardial blood volume and its
dynamic changes on myocardial T1 has never been in-
vestigated previously. In this work we used a vasodilator
stress agent, adenosine [33] to study directly the vascular
compartment contribution to the native T1 in both nor-
mal and diseased conditions. We demonstrate for the first
time a clear effect of the intravascular compartment dur-
ing stress on myocardial T1 in normal controls and AS
patients. The attenuated stress T1 response in severe AS
may reflect reduced myocardial perfusion reserve in line
with previous studies [16,34]. This observation paves way
for coronary reserve assessments with stress T1-mapping
as an alternate biomarker, free of intravascular administra-
tion of Gadolinium contrast, and insensitive to potential
heart rate dependencies due to properties of the under-
lying T1 mapping technique [19].
Diffuse myocardial fibrosis may not be the sole
contributor to increased myocardial T1 and extracellular
volume in severe AS
The increased native T1 and ECV in AS is traditionally
attributed to interstitial expansion due to diffuse fibrosis.
However, if T1 changes were due to interstitial expan-
sion and diffuse fibrosis only, then we would expect an
increase in T1 values in AS both at baseline and during
the stress due to presence of increased interstitial water.
In contrast, we found that stress T1 values were similar
for control and AS patients. The complete normalization
of both resting T1 and vasodilator T1 response after
AVR although the percentage of LV myocardium that
shows focal fibrosis is unchanged indicates a significant
role of the intravascular compartment in myocardial tis-
sue pathology in AS. This concurs with a previous study
by Eberli et al. who demonstrated markedly increasedFigure 4 Proposed myocardial water compartments in aortic stenosis
stress in patients with aortic stenosis pre and post AVR, and controls (left –
contributed to by vascular responses instead of interstitial space expansion
cross-sections are for qualitative comparison only and not to scale.resting blood flow and reduced coronary flow reserve in
aortic valve disease, but maximum flow during stress is
similar to patients who had valve replacement and nor-
mal controls [30].
Figure 4 illustrates the proposed changes of the water
compartment in the myocardial tissue of AS patients. This
scenario is fully consistent with the interpretation of the
impact of the reactive partial blood volume of blood,
which has significantly more water content and a longer
T1 than the mix of tightly packed myocytes separated by
the true interstitial space. The effective myocardial T1
resulting from such simplified two-compartmental model
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to fit observed overall T1 in normal controls at restð Þ
The change in partial blood volume itself is hard to
measure directly and is usually approximated as about a
third of the corresponding change in the flow [37]. As-
suming the maximal blood flow change in normal con-
trols is about 3 fold [38], the normal resting blood volume
in the myocardium should approximately double to 20% in
normal controls with the respective simulated T1 reactivi-
ty ~6%, in excellent agreement with our observations. In
AS patients before AVR, the same model implicates that
the resting blood volume increased to ~14%, with respect-
ive flow response reduced to ~110%, in order to approxi-
mate the observed stress T1 reactivity at ~3.5%.. Proposed changes in myocardial water compartments at rest and
adapted from Figure 1). The T1 response to adenosine was mainly
which may be negligible. Note that T1 and volumes from vascular
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part of a CMR protocol that includes T1 mapping for ECV
estimation, post contrast T1 should be acquired after a suf-
ficient time has passed to ensure that myocardium is no
longer in hyperemic state. Furthermore, our findings may
also have important clinical implications as T1 changes in
AS may serve as a marker for determining disease progress
and therapeutic response, although this should be explored
further in larger studies with a wider spectrum of AS
severity.
Study limitations
Our study population was small in line with a proof of con-
cept study, and therefore confirmation in larger scale stud-
ies is warranted. We performed a single mid-ventricular
short-axis T1-map during stress, which represents a sam-
ple of the myocardium rather than the entire left ventricle;
however we believe that the myocardial changes in severe
AS are mostly homogenous, and this is therefore unlikely
to affect the results. Although good agreement of normal
resting myocardial T1 has been documented between
ShMOLLI and MOLLI T1-mapping techniques [19],
the numeric results in T1 in disease and T1 vascular re-
activity may not hold between different methods where
multiple parametric dependencies between T1, T2 and
magnetization transfer (MT) in multiple tissue compart-
ments may affect the effect size [8,13,14,39,40]. Further re-
search is required to fully model the interaction between
flow, volume and blood T1, which have been shown to be
strongly stratified by vessel size in the brain, but not deeply
studied in the heart [37].
Conclusions
Patients with severe aortic stenosis demonstrated increased
resting myocardial T1 values, which correlated with aortic
valve area, LVH and impaired myocardial perfusion reserve,
but achieved the same maximal stress T1 response as
healthy controls. The abnormal resting myocardial T1 and
ΔT1 stress response normalized seven months post-AVR
without specific treatment towards regression of myocardial
fibrosis. Our findings support the concept that the intravas-
cular compartment is a significant contributor to myocar-
dial T1 relaxation times, and provide a novel mechanism to
explain the T1 changes previously only attributed to diffuse
myocardial fibrosis in the interstitial compartment. Coron-
ary reserve may be assessed using native T1-mapping and
this may serve as an alternate biomarker for disease severity
and therapeutic response in aortic stenosis.
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